Bank loan default disclosed: about Rs 15.57 crore overdue across two lenders

Loan classified NPACredit & Debt View source PDF Explain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-3.5%Reaction day

₹33.35

prior close

₹33.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.1%-3.3% vs market

Pharmaceuticals peers, median of 173sector-0.3%-3.2% vs sector

On the reaction day the stock moved 3.3 pts less than Nifty Microcap 250 and 3.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+2.4

10m

+2.3

15m

+0.6

30m

-1.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-3.5-0.1-3.3-0.3-3.2

Next day

-4.5+0.7-5.2+0.6-5.1

+2.5+2.3+0.2+1.5+1.0

-1.2+2.2-3.4+1.6-2.8

-3.4+2.6-6.1+1.9-5.3

-3.4+3.9-7.4+2.5-6.0

-5.1+2.7-7.8+0.9-6.0

15d

-5.5-1.2-4.3-3.0-2.5

-7.0-0.2-6.9-3.8-3.2

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mangalam Drugs and Organics disclosed defaults on cash credit accounts with Bank of Maharashtra (Rs 9.51 crore overdue since 17 Oct 2025) and Bank of Baroda (Rs 6.06 crore since 20 Oct 2025). Combined overdue is about Rs 15.57 crore, both defaults exceeding 30 days. Company says it is arranging to clear dues. This is a subsequent intimation following an earlier disclosure dated 16 Feb 2026.

Likely market impact

Loan default signals financial stress; may pressure stock and raise future borrowing costs. Shareholders should monitor resolution closely.